Read latest edition of Gowling WLG Insights monthly news and articles

Radient announce it has entered into an agreement with Canaccord Genuity Corp., as lead underwriter, to purchase, on a bought deal basis, 16,700,000 units of the Company.

Alberta has one of the largest, most mature, detailed and comprehensive health system data depositories in Canada. As such, Alberta is poised to become a global leader in Real World Evidence (RWE) generation.

Freezing things is an imperfect process whether freezing food or freezing cells.

GlycoNet, along with partner institutions, recently awarded more than $3.5M in grants to fund exploratory research in the area of glycomics to benefit human health.

BioAlberta is pleased to announce that Robb Stoddard has joined our team and brings a wealth of knowledge of the life sciences industry of Alberta.

The acquisition is part of a strategic plan for the company to attack diabetes and obesity with natural, nutritious, healthy and delicious energy bars and confectionary with NO SUGAR.

We are in the process of obtaining regulatory approval to use our product (Occlusin® 500) to treat BPH.

The Centre for Aging + Brain Health Innovation (CABHI) is excited to launch its third round of the I2P2 program.

Specializing in boxes, cartons and paper packaging, Inkubate Packaging hope to capitalize on their experience in the hemp industry, with the new marijuana industry.

BioAlberta will relocate our office mid-May. Please drop by and visit us at our new space: #202, 10055 - 106 Street, Edmonton.

OncoQuest is a biopharmaceutical company focused on the development and commercialization of immunotherapeutic products for the treatment of cancer.

Two U of A professors receive a one year research grant to study 'sugars in biology' which may unlock clues about Alzheimer's, a disease that affects more than 25,000 Canadians, annually.

Lowen’s Natural Skincare is pleased to announce that it has undertaken a brand refresh with its partners at the marketing agency Local Propeller.

Madenco, a subsiduary of Quest Pharmatech, announce a licensing agreement with Stanford University, for patented EGF wound healing technology.